JPH0134205B2 - - Google Patents
Info
- Publication number
- JPH0134205B2 JPH0134205B2 JP56155731A JP15573181A JPH0134205B2 JP H0134205 B2 JPH0134205 B2 JP H0134205B2 JP 56155731 A JP56155731 A JP 56155731A JP 15573181 A JP15573181 A JP 15573181A JP H0134205 B2 JPH0134205 B2 JP H0134205B2
- Authority
- JP
- Japan
- Prior art keywords
- saponin
- absorption
- saponins
- minutes
- orally administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000010521 absorption reaction Methods 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 10
- 239000003814 drug Substances 0.000 claims description 10
- 150000008130 triterpenoid saponins Chemical class 0.000 claims description 7
- 239000004480 active ingredient Substances 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 3
- 239000003782 beta lactam antibiotic agent Substances 0.000 claims description 2
- 239000002132 β-lactam antibiotic Substances 0.000 claims 1
- 229940124586 β-lactam antibiotics Drugs 0.000 claims 1
- 229930182490 saponin Natural products 0.000 description 11
- 150000007949 saponins Chemical class 0.000 description 11
- 235000017709 saponins Nutrition 0.000 description 11
- 230000000144 pharmacologic effect Effects 0.000 description 6
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- SMRPGWBDLOQHOS-UHFFFAOYSA-N 5-[4,5-dihydroxy-6-(hydroxymethyl)-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxy-3,4-dihydroxy-6-[[9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1H-picen-3-yl]oxy]oxane-2-carboxylic acid Chemical compound OC1C(O)C(O)C(C)OC1OC1C(OC2C(OC(C(O)C2O)C(O)=O)OC2C(C3C(C4C(C5(CCC6(C)C(O)CC(C)(C)CC6C5=CC4=O)C)(C)CC3)(C)CC2)(C)CO)OC(CO)C(O)C1O SMRPGWBDLOQHOS-UHFFFAOYSA-N 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- BMWPBKOFJSHJAW-UHFFFAOYSA-N Saponin B Natural products CC1(C)CCC2(CCC3(C)C(=CCC4C5(C)CCC(OC6OC(CO)C(O)C(OC7OC(CO)C(O)C(O)C7O)C6=O)C(C)(C)C5CCC34C)C2C1)C(=O)O BMWPBKOFJSHJAW-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- PPRSVUXPYPBULA-UHFFFAOYSA-N saponin A Natural products CC1(C)CCC2(CCC3(C)C(=CCC4C5(C)CCC(OC6OC(CO)C(O)C(O)C6=O)C(C)(C)C5CCC34C)C2C1)C(=O)O PPRSVUXPYPBULA-UHFFFAOYSA-N 0.000 description 3
- 241000208340 Araliaceae Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 241000580938 Sapindus Species 0.000 description 2
- KLOHDWPABZXLGI-YWUHCJSESA-M ampicillin sodium Chemical compound [Na+].C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C([O-])=O)(C)C)=CC=CC=C1 KLOHDWPABZXLGI-YWUHCJSESA-M 0.000 description 2
- 229960001931 ampicillin sodium Drugs 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- LVTJOONKWUXEFR-UEZXSUPNSA-N protodioscin Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@H](O)[C@@H](O)[C@H](C)O1)O)O[C@@H]1CC2=CC[C@H]3[C@@H]4C[C@@H]5O[C@]([C@H]([C@@H]5[C@@]4(C)CC[C@@H]3[C@@]2(C)CC1)C)(O)CC[C@@H](C)CO[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O LVTJOONKWUXEFR-UEZXSUPNSA-N 0.000 description 2
- QDQWGYLCDZBAMD-UHFFFAOYSA-N saponin C Natural products CC1C2C3CCC4C5(C)CCC(O)C(C)(COC6OC(CO)C(O)C(O)C6O)C5CCC4(C)C3(C)CCC27C8OC8C1(C)OC7=O QDQWGYLCDZBAMD-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- NTWLPZMPTFQYQI-UHFFFAOYSA-N (3alpha)-olean-12-ene-3,23-diol Natural products C1CC(O)C(C)(CO)C2CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC3C21C NTWLPZMPTFQYQI-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000722953 Akebia Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 241000230612 Caulophyllum robustum Species 0.000 description 1
- 241000202567 Fatsia japonica Species 0.000 description 1
- 229930183217 Genin Natural products 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- GCGBHJLBFAPRDB-UHFFFAOYSA-N Hederagenin Natural products CC1(C)CCC2(CCC3(C)C4CCC5C(C)(CO)C(O)CCC5(C)C4CC=C3C2C1)C(=O)O GCGBHJLBFAPRDB-UHFFFAOYSA-N 0.000 description 1
- 241001190114 Lecaniodiscus cupanioides Species 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- GCGBHJLBFAPRDB-KCVAUKQGSA-N Scutellaric acid Natural products CC1(C)CC[C@@]2(CC[C@@]3(C)[C@@H]4CC[C@H]5[C@@](C)(CO)[C@H](O)CC[C@]5(C)[C@H]4CC=C3[C@@H]2C1)C(=O)O GCGBHJLBFAPRDB-KCVAUKQGSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 description 1
- 230000002183 duodenal effect Effects 0.000 description 1
- 210000000990 duodenal loop Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- PGOYMURMZNDHNS-MYPRUECHSA-N hederagenin Chemical compound C1C[C@H](O)[C@@](C)(CO)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C PGOYMURMZNDHNS-MYPRUECHSA-N 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- NWMIYTWHUDFRPL-UHFFFAOYSA-N sapogenin Natural products COC(=O)C1(CO)C(O)CCC2(C)C1CCC3(C)C2CC=C4C5C(C)(O)C(C)CCC5(CCC34C)C(=O)O NWMIYTWHUDFRPL-UHFFFAOYSA-N 0.000 description 1
- 229940048730 senega Drugs 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 150000005856 steroid saponins Chemical class 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56155731A JPS5857400A (ja) | 1981-09-30 | 1981-09-30 | 薬物吸収補助剤 |
| US06/354,289 US4501734A (en) | 1981-03-06 | 1982-03-03 | Promotion of absorption of drugs administered through the alimentary system |
| DE19823207841 DE3207841A1 (de) | 1981-03-06 | 1982-03-04 | Adjuvans-zubereitung |
| CH1350/82A CH652931A5 (fr) | 1981-03-06 | 1982-03-05 | Composition adjuvante pour aider l'absorption d'une substance pharmacologiquement active, administree par l'intermediaire de l'appareil digestif. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56155731A JPS5857400A (ja) | 1981-09-30 | 1981-09-30 | 薬物吸収補助剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5857400A JPS5857400A (ja) | 1983-04-05 |
| JPH0134205B2 true JPH0134205B2 (zh) | 1989-07-18 |
Family
ID=15612215
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56155731A Granted JPS5857400A (ja) | 1981-03-06 | 1981-09-30 | 薬物吸収補助剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5857400A (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103007280B (zh) * | 2013-01-18 | 2014-02-19 | 辽宁益康生物股份有限公司 | 仔猪大肠杆菌病冻干血清免疫球蛋白制剂及其制备工艺 |
| CN103041388B (zh) * | 2013-01-18 | 2014-02-19 | 辽宁益康生物股份有限公司 | 仔猪大肠杆菌病卵黄免疫球蛋白生物制剂及其制备工艺 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4146615A (en) * | 1977-01-20 | 1979-03-27 | Laboratoires Sarget | Chrysanthellum plant extract |
-
1981
- 1981-09-30 JP JP56155731A patent/JPS5857400A/ja active Granted
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4146615A (en) * | 1977-01-20 | 1979-03-27 | Laboratoires Sarget | Chrysanthellum plant extract |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5857400A (ja) | 1983-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU686656B2 (en) | Compositions containing piperine | |
| EP1022022B1 (en) | Composition for inhibiting increase of blood sugar level or lowering blood sugar level | |
| US8586569B2 (en) | Betulonic and betulinic acid derivatives | |
| WO2006056129A1 (fr) | Compositions d'alcaloides d'huperzia serrata comportant de l'huperzine a et de l'huperzine b et preparation de ces compositions | |
| CN101541317B (zh) | 2,3-二甲氧基-5-甲基-6-(10-羟癸基)-1,4-苯醌的粘膜给药 | |
| WO2009067891A1 (fr) | Composés de triterpènephénol solubles dans l'eau ayant une activité anti-tumorale et leur préparation | |
| JP2003531813A (ja) | ナフトキノン誘導体および結核の治療および制御におけるその使用 | |
| EP1001799A1 (de) | Pharmazeutische zusammensetzung enthaltend peptichemio | |
| JPH0134205B2 (zh) | ||
| JPS6041656A (ja) | 新規アミノ酸誘導体の製法 | |
| KR20030023232A (ko) | 인삼 또는 돌외로부터 사포닌을 추출하는 방법 및 이방법에 따라 추출된 사포닌을 함유하는 식품 | |
| JP3949198B2 (ja) | Ｖ−ＡＴＰａｓｅ 脱共役 Ｈ＋ ポンプ阻害剤 | |
| KR101082802B1 (ko) | 8-하이드록시클로미프라민 또는 그의 염을 포함하는 조루의 예방 또는 치료용 약학 조성물 | |
| KR100564383B1 (ko) | 진세노사이드 유도체의 제조방법 | |
| JPH0678231B2 (ja) | 血液粘度低下剤 | |
| KR100547253B1 (ko) | 암 예방 및 치료에 유효한 진세노사이드 유도체 | |
| CN111647036A (zh) | 一类Ocotillol型酯化衍生物及其制备方法和制作抗炎药物的用途 | |
| JPH09241157A (ja) | リソスペルメートｂ含有肝臓保護作用医薬組成物 | |
| US4436732A (en) | Medicated compound for treating diseases infected by virus of the herpes group | |
| JP2631688B2 (ja) | グリチルレチン酸誘導体からなる医薬品 | |
| JPH0753385A (ja) | アルコール吸収抑制剤 | |
| US8557784B2 (en) | Glycyrrhizinates of morphinan derivatives | |
| KR20060086781A (ko) | 진세노사이드 유도체 및 그의 용도 | |
| JPS609023B2 (ja) | インジルビン誘導体およびそれを含有する抗腫瘍剤 | |
| JPS6215529B2 (zh) |